Saturday 17 October 2026
Export MCTA’s income statement to Excel — free account
Charming Medical Limited
MCTA Healthcare Medical Care Facilities
Charming Medical Limited’s revenue for fiscal 2026 (year ended March 2026) was $4.8 million, down 22.7% from fiscal 2025.
29.36
0.00
0.00%
Follow MCTA
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to March
| Group | Line | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | 0.00 | 29.36 |
Analyst estimates 2027–2029 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | 31.24 | 29.36 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 49 | — | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.00 | 0.13 | 0.00 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 6 | 6 | 5 | ||||
| Gross margin, % | — | — | — | — | — | — | — | 99.81 | 99.75 | 99.27 | |||||
| EBT | — | — | — | — | — | — | — | 1 | 1 | 0 | |||||
| EBT margin, % | — | — | — | — | — | — | — | 16.68 | 23.07 | 2.78 | |||||
| Net income | — | — | — | — | — | — | — | 1 | 0 | 0 | |||||
| Depreciation | — | — | — | — | — | — | — | 0 | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | 0.39 | 0.41 | 0.30 | ||||
| Earnings | — | — | — | — | — | — | — | 0.05 | 0.08 | 0.00 | |||||
| Cash flow | — | — | — | — | — | — | — | 0.02 | 0.03 | (0.08) | |||||
| Capex | — | — | — | — | — | — | — | (0.01) | (0.02) | (0.02) | |||||
| Free cash flow | — | — | — | — | — | — | — | 0.01 | 0.01 | (0.09) | |||||
| Book value | — | — | — | — | — | — | — | (0.07) | 0.00 | 0.32 | |||||
| Shares, m | — | — | — | — | — | — | — | 15 | 15 | 16 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | ||||
| P/S | — | — | — | — | — | — | — | — | — | — | |||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | |||||
| EV/FCF | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | 0 | 0 | (1) | ||||
| Capex | — | — | — | — | — | — | — | 0 | 0 | 0 | |||||
| Free cash flow | — | — | — | — | — | — | — | 0 | 0 | (2) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | (2) | (2) | 4 | ||||
| Total debt | — | — | — | — | — | — | — | 0 | 0 | 0 | |||||
| Net debt | — | — | — | — | — | — | — | (2) | (2) | (6) | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | (1) | 0 | 5 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | 0.00 | 23.43 | (0.30) | ||||
| ROIC | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | |||||
| ROE | — | — | — | — | — | — | — | 0.00 | (218.63) | (0.86) | |||||
Negative figures in brackets.
Fiscal years to Mar 2026 · fundamentals updated 12 Oct 2026
Charts ten years each
Charming Medical Limited vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| HCSG Healthcare Services Group, Inc. | $1.5B | 12.2× | 19.2× | +2.69% (above 0%: growing) | n/m | −26.02% (below 0%: shrinking) | 15.89% | 4.72% | Compare |
| NUTX Nutex Health Inc. | $1.4B | 7.1× | 6.3× | −13.62% (below 0%: shrinking) | n/m | +19.44% (above 0%: growing) | 67.04% | 57.75% | Compare |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 504× | 27.7× | +8.47% (above 0%: growing) | −56.90% (below 0%: shrinking) | −8.24% (below 0%: shrinking) | 19.59% | 10.25% | Compare |
| INNV InnovAge Holding Corp. | $1.2B | — (loss-making) | 17.2× | +18.31% (above 0%: growing) | n/m | +85.44% (above 0%: growing) | 23.88% | 3.87% | Compare |
| STLN Starling Oncology, Inc. | $690.9M | — (loss-making) | — (loss-making) | +34.62% (above 0%: growing) | n/m | +196.69% (above 0%: growing) | 16.84% | (2.86%) | Compare |
| MCTA Charming Medical Limited | $497.3M | — | — | — | — | — | — | — | |
| CYH Community Health Systems, Inc. | $421.6M | 1.5× | — (loss-making) | −9.83% (below 0%: shrinking) | −75.83% (below 0%: shrinking) | +500.00% (above 0%: growing) | 85.81% | 13.77% | Compare |
| AUNA Auna S.A. | $392.3M | 76.0× | 5.2× | +20.51% (above 0%: growing) | −61.29% (below 0%: shrinking) | +121.08% (above 0%: growing) | 35.72% | 13.09% | Compare |
| SRTA Strata Critical Medical, Inc. | $384.0M | 9.0× | — (loss-making) | +60.74% (above 0%: growing) | n/m | +150.33% (above 0%: growing) | 20.98% | (7.46%) | Compare |
| Median of peers | $960.4M | 10.6× | 17.2× | +13.39% | −61.29% | +103.26% | 22.43% | 7.49% |
Charming Medical Limited (MCTA) key facts
- Concern: Charming Medical Limited’s revenue for fiscal 2026 (year ended March 2026) was $4.8 million, down 22.7% from fiscal 2025.
- Charming Medical Limited (MCTA) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
- As of October 14, 2026, MCTA traded at $29.36, a market capitalization of $497.3 million.
- Return on equity was −0.86% and debt-to-equity 0.69.
- Its Piotroski F-score is 2 out of 9 and its Altman Z-score is 61.64 (safe zone) for fiscal 2026.